Error: Could not add to watchlist. X

Amicus Therapeutics Inc

+ Watchlist
FOLD:US
NASDAQ GM
13.87
USD
0.16
1.18%
As of 14:12:19 ET on 07/07/2015.
Open
14.03
Day Range
13.50 - 14.04
Volume
885,225
Previous Close
14.03
52Wk Range
3.50 - 14.65
1 Yr Return
253.59%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.94
Market Cap (b USD)
1.542
Shares Outstanding (m)
113.356
Price/Sales (TTM)
1,279.08
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.
ADDRESS
6 Cedar Brook Drive
Cranbury, NJ 08512
United States
PHONE
1-609-662-2000
  • John F Crowley
    Chairman/CEO
  • Bradley L Campbell
    President/COO
  • William D Baird "Chip"
    Chief Financial Officer
  • Jay Barth
    Chief Medical Ofcr
  • Hung Do
    Chief Science Officer
Show More